Categories
Pharmaceutical

Demand Of Breast Cancer Diagnostics Market To Rise At A Healthy CAGR Of Around 7% Over The Decade

A recently revised survey on the breast cancer diagnostics market by Fact.MR predicts demand to rise at a healthy CAGR of around 7% over the decade. The survey also states that, the global breast cancer diagnostics market was valued at around US$ 4 Bn in 2020, and is slated to expand almost 2X by 2031.

The Demand analysis of Breast Cancer Diagnostics Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Breast Cancer Diagnostics Market across the globe.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=55

Global Market CAGR (2021-2031) 7%
North America Revenue Share (2020) 45%
Global Market Value (2020) US$ 4 Bn
Hospital-associated Labs Market Share (2020) 50%

Key Segments of Breast Cancer Diagnostics Industry Survey

  • By Test Type:

    • CA Tests for Breast Cancer
    • BRCA Test for Breast Cancer
    • ER & PR Test for Breast Cancer
    • CEA Test for Breast Cancer
    • KRAS Mutation Test for Breast Cancer
    • HER 2 Test for Breast Cancer
    • PSA Test for Breast Cancer
    • EGFR Mutation Test for Breast Cancer
    • Immunohistochemistry for Breast Cancer
    • Others
  • By End User:

    • Hospital Associated Labs
    • Independent Diagnostic Laboratories
    • Cancer Research Institutes
    • Others

A comprehensive estimate of the Breast Cancer Diagnostics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the Sales of Breast Cancer Diagnostics during the forecast period. Price point comparison by region with the global average price is also considered in the

The Market survey of Breast Cancer Diagnostics offers a comprehensive analysis of diverse features, including production capacities analysis of Breast Cancer Diagnostics, demand, product developments, revenue generation, and Size of Breast Cancer Diagnostics Market across the globe.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=55

Some Notable Offerings by Fact.MR Report on Breast Cancer Diagnostics market:

  • We will provide you an analysis of the extent to which this Breast Cancer Diagnostics market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

Buy Now  https://www.factmr.com/checkout/55

After reading the Market insights of Breast Cancer Diagnostics Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Breast Cancer Diagnostics market revenue.
  • Study the growth outlook of Breast Cancer Diagnostics market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Breast Cancer Diagnostics market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Breast Cancer Diagnostics Market Players.

How Fact.MR Assists in Making Strategic Moves For Breast Cancer Diagnostics Market Manufacturer?

  • The data provided in the Breast Cancer Diagnostics market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

For More Insights- https://www.biospace.com/article/increasing-incidence-of-multidrug-resistant-bacterial-infections-is-augmenting-the-demand-for-rapid-medical-diagnostics-kits-fact-mr/

About Fact.MR:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

 Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Breast Cancer Diagnostics Market Overview By Industry Chain Information, Upstream Raw Materials & Downstream Industry 2022 – 2031

A recently revised survey on the breast cancer diagnostics market by Fact.MR predicts demand to rise at a healthy CAGR of around 7% over the decade. The survey also states that, the global breast cancer diagnostics market was valued at around US$ 4 Bn in 2020, and is slated to expand almost 2X by 2031.

The Demand analysis of Breast Cancer Diagnostics Market offers a comprehensive analysis of diverse features, demand, product developments, revenue generation, and sales of Breast Cancer Diagnostics Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=55

Key Segments of Breast Cancer Diagnostics Industry Survey

  • By Test Type:

    • CA Tests for Breast Cancer
    • BRCA Test for Breast Cancer
    • ER & PR Test for Breast Cancer
    • CEA Test for Breast Cancer
    • KRAS Mutation Test for Breast Cancer
    • HER 2 Test for Breast Cancer
    • PSA Test for Breast Cancer
    • EGFR Mutation Test for Breast Cancer
    • Immunohistochemistry for Breast Cancer
    • Others
  • By End User:

    • Hospital Associated Labs
    • Independent Diagnostic Laboratories
    • Cancer Research Institutes
    • Others

Request methodology https://www.factmr.com/connectus/sample?flag=RM&rep_id=55

Some Notable Offerings by Fact.MR Report on Breast Cancer Diagnostics market:

  • We will provide you an analysis of the extent to which this Breast Cancer Diagnostics market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

To get all-in insights on the regional landscape of the Breast Cancer Diagnostics Market, buy now:-https://www.factmr.com/checkout/55

After reading the Market insights of Breast Cancer Diagnostics Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Breast Cancer Diagnostics market revenue.
  • Study the growth outlook of Breast Cancer Diagnostics market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Breast Cancer Diagnostics market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Breast Cancer Diagnostics Market Players.

How Fact.MR Assists in Making Strategic Moves For Breast Cancer Diagnostics Market Manufacturer?

  • The data provided in the Breast Cancer Diagnostics market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

For More Insight- https://www.biospace.com/article/radiation-dermatitis-treatment-market-surging-at-5-percent-cagr-rising-prevalence-of-skin-cancer-drives-growth-fact-mr-study/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for BRCA Tests for Breast Cancer Diagnostics is Anticipated to be the Most Prominent in the Marketplace

250 Pages Breast Cancer Diagnostics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Breast Cancer Diagnostics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Breast Cancer Diagnostics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=55

Digital Transformation in Healthcare Presenting Opportunities for Breast Cancer Diagnostics Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Breast Cancer Diagnostics market.

Breast cancer diagnostics market regional analysis by Fact.MR

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=55

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Breast Cancer Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Breast Cancer Diagnostics

The report offers actionable and valuable market insights of Breast Cancer Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Breast Cancer Diagnostics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Breast Cancer Diagnostics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Breast Cancer Diagnostics Market.

Market Snapshot

A recently revised survey on the breast cancer diagnostics market by Fact.MR predicts demand to rise at a healthy CAGR of around 7% over the decade. The survey also states that, the global breast cancer diagnostics market was valued at around US$ 4 Bn in 2020, and is slated to expand almost 2X by 2031.

Global Market CAGR (2021-2031) 7%
North America Revenue Share (2020) 45%
Global Market Value (2020) US$ 4 Bn
Hospital-associated Labs Market Share (2020) 50%

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/55

Key Segments of Breast Cancer Diagnostics Industry Survey

·         By Test Type:

    • CA Tests for Breast Cancer
    • BRCA Test for Breast Cancer
    • ER & PR Test for Breast Cancer
    • CEA Test for Breast Cancer
    • KRAS Mutation Test for Breast Cancer
    • HER 2 Test for Breast Cancer
    • PSA Test for Breast Cancer
    • EGFR Mutation Test for Breast Cancer
    • Immunohistochemistry for Breast Cancer
    • Others

·         By End User:

    • Hospital Associated Labs
    • Independent Diagnostic Laboratories
    • Cancer Research Institutes
    • Others

Competitive Landscape

Prime providers of breast cancer diagnostics are striving to come up with diagnostic solutions that offer early detection of breast cancer. Key market players are also investing in the research & development of diagnostic solutions that are fast, accurate, and cost-efficient.

  • Vice President of India, Shri M. Venkaiah Naidu, in September 2021, launched the first-of-its-kind breast cancer helpline, set up by the Ushalakshmi Breast Cancer Foundation. This is a new step for the nation to spread awareness about breast cancer.
  • Elizabeth Hurley, actress and model, launched a cancer support center in London in September 2021, ahead of the cancer awareness month. The support centre was named Future Dreams House.
  • In October 2021, to increase awareness about breast cancer, WellSpan Health and Capital Blue Cross, in collaboration, launched a mobile mammography motor coach, which is in accordance with their goal to increase screening for breast cancer across five countries.

Fact.MR, a market research and competitive intelligence provider, recently updated its analysis on the breast cancer diagnostics market which was valued at around US$ 4 Bn in 2020. The latest in-depth analysis suggests that the global market is expected to expand at a robust CAGR of around 7% over the next ten years.

In 2021, WHO stated that, globally, breast cancer is the most common type of cancer, with as much as more than 2.3 Mn new cases being recorded. This increasing instance of breast cancer is largely shaping demand for breast cancer diagnostics. Rising awareness about breast cancer via various government initiatives and various cancer organizations is boosting market growth.

Demand for cost-effective, technologically advanced, efficient, and accurate diagnostic solutions is anticipated to be a major trend in the industry over the decade. Imaging and screening technologies are majorly shaping the diagnostics industry, as their popularity and adoption is increasing. Cost-effective diagnostic solutions in emerging and developing economies such as India and Brazil are anticipated to drive market expansion.

Breast cancer diagnostic providers are focusing on developing new instruments and devices that facilitate the early detection of breast cancer, which is vital in combating the disease effectively. Investments in research are also anticipated to see a major increase over the next ten years as focus is on treating and combating breast cancer.

Key Takeaways from Market Study

  • Global demand for breast cancer diagnostics to rise at healthy CAGR of nearly 7% over the decade.
  • Rising demand for affordable and cost-effective solutions in emerging nations such as India and Brazil expected to drive demand.
  • Global breast cancer diagnostics market raked in revenue worth US$ 4 Bn in 2020.
  • India and China expected to lead demand for breast cancer diagnostics in Asia Pacific.
  • Hospital-associated labs accounted for nearly 50% market share in 2020.
  • In terms of revenue, North America held around 45% share of global market in 2020.

“Rising number of active breast cancer cases is a major concern across the globe, and non-existence of early diagnostic solutions is a major factor influencing the landscape,” says a Fact.MR analyst.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Breast Cancer Diagnostics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Breast Cancer Diagnostics Historical volume analysis: The report provides a comparison of Breast Cancer Diagnostics’s historical sales and projected sales performance for 2021-2031.
  • Breast Cancer Diagnostics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Breast Cancer Diagnostics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Breast Cancer Diagnostics Consumption by demographics: The report investigates consumer behavior affecting Breast Cancer Diagnostics demand outlook for the assessment period. Effect of their keenness for digital trends on Breast Cancer Diagnostics market is carefully analyzed
  • Post COVID consumer spending on Breast Cancer Diagnostics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Breast Cancer Diagnostics market growth.

More Valuable Insights on Breast Cancer Diagnostics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Breast Cancer Diagnostics, Sales and Demand of Breast Cancer Diagnostics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

Breast Cancer Diagnostics Market – Hospital-associated Labs to Remain the Largest End-Users, Finds Fact.MR

Award winning market research company Fact.MR has conducted a research study on the global demand of breast cancer diagnostics market for the forecast period of 2021 to 2031. As per its analysis, the market is expected to register a moderate growth, primarily underpinned by the growing cases of breast cancer. Growth prospects for the upcoming decade are also positive, as the market is forecast to register 4.7% CAGR through 2021 and beyond.

According to Fact.MR, the market is poised to benefit immensely on the back of technological advancement in the diagnostic platforms. Introduction of hybrid imaging instruments and the adoption of artificial intelligence in the field is expected to yield positive response for the breast cancer diagnostics market. Furthermore, increasing cases of breast cancer among older female population is augmenting the market growth.

 

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=55

 

According to U.S. breast cancer statistics for 2021, an estimated 281,500 new cases of invasive breast cancer are expected to be diagnosed in the women within United States, along with 49,290 new cases of non-invasive breast cancer. Additionally, around 3.8 million women were recorded with the history of breast cancer in January 2021. Hence, with rising burden of these new cases, the market is expected to register a steady growth through 2021 and beyond.

 

8 Estimations for the Global Breast Cancer Diagnostics Market
  1. By test type, BRCA will remain dominant in the global breast cancer diagnostics market.
  2. CA test for diagnostics of breast cancer is expected to register the highest CAGR through 2022 in the market, followed by ER & PR. Revenue from ER & PR, and CA tests will continue to be low throughout the forecast period.
  3. HER 2 test is expected to remain the second largest segment among test type, in the market. However, EGFR mutation test is estimated to account for low revenues in the global market for breast cancer diagnostics.
  4. North America will continue to be the largest market for breast cancer diagnostics. Revenues from breast cancer diagnostics market in North America is estimated to surpass US$ 800 Mn by 2022-end.
  5. Europe will remain the second most lucrative region for the breast cancer diagnostics market. However, markets in Japan, and Middle East & Africa (MEA) are anticipated to witness a sluggish expansion throughout the forecast period.
  6. Hospital-associated labs will remain sought-after among end-users for breast cancer diagnostics around the world. Revenues from breast cancer diagnostics will remain largest in hospital-associated labs, followed by the independent diagnostic laboratories.
  7. Cancer research institutes are anticipated to exhibit the highest CAGR during the forecast period. Between 2017 and 2022, cancer research institutes are estimated to create absolute $ opportunity of US$ 107.3 Mn.

 

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=55

 

Competitive Landscape

Key players operating in the breast cancer diagnostics market profiled by Fact.MR includes Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific Inc., GE Healthcare, Siemens AG, Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, Astra Zeneca PLC, Myriad Genetics Inc. and Quest Diagnostics Incorporated.

On February 22nd 2021, Medifirst Solutions Inc., announced a clinical study for a breast cancer medical device for real-time margin detection to provide direct support during lumpectomy cancer surgery.

Also, in March 2021, Celcuity Inc., a clinical storage biotechnology company announced the breast cancer clinical trial collaboration with MD Anderson, Novartis, and Puma Biotechnology to identify new targeted therapeutic options for cancer patients through new drug study regimen.

Furthermore, Koios Medical Inc., a fast-growing developer of artificial intelligence software for physicians announced the CE Mark approval and European Market Launch on 16th March 2021, for breast cancer detection AI software.

 

Get More Insights – https://www.biospace.com/article/breast-cancer-diagnostics-market-sales-set-to-grow-by-4-7-percent-to-surpass-us-2000-mn-by-2022-end-fact-mr/

 

Explore Fact.MR’s Coverage on the Healthcare Domain

Automated Breast Ultrasound Systems Market: A recent study by Fact.MR on the automated breast ultrasound systems market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Silicone Gel Filled Breast Implant Market: Fact.MR gives a detailed assessment of silicone gel filled breast implant market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Breast Reconstruction Market: Fact.MR delivers an in-depth analysis on global breast reconstruction market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight:https://www.factmr.com/report/55/breast-cancer-diagnostics-market
Press Release:https://www.factmr.com/media-release/41/breast-cancer-diagnostics-market